Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS
The TRIUMPH Phase 3 global registrational clinical development program, which began in 2023, has enrolled more than 5,800 participants and additional results are anticipated next year
For a better understanding of the side effects you may get with Mounjaro, including stomach troubles and other issues, go check out our detailed blog post
MGMA Corporate Member
7 Autoimmune diseases manifest over a number of years, developing from: The early stages of autoimmune disease present a critical opportunity to intervene prior to overt disease and tissue damage by addressing nutrient imbalances and gastrointestinal barrier integrity